These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20881017)

  • 1. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.
    Cano SJ; Posner HB; Moline ML; Hurt SW; Swartz J; Hsu T; Hobart JC
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1363-8. PubMed ID: 20881017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods.
    Hobart J; Cano S; Posner H; Selnes O; Stern Y; Thomas R; Zajicek J;
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S4-9. PubMed ID: 23253777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
    J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.
    Hobart J; Cano S; Posner H; Selnes O; Stern Y; Thomas R; Zajicek J;
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S10-20. PubMed ID: 23253779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial.
    Weyer G; Erzigkeit H; Kanowski S; Ihl R; Hadler D
    Int Psychogeriatr; 1997 Jun; 9(2):123-38. PubMed ID: 9309486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.
    Doraiswamy PM; Kaiser L; Bieber F; Garman RL
    Alzheimer Dis Assoc Disord; 2001; 15(4):174-83. PubMed ID: 11723368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials.
    Doraiswamy PM; Bieber F; Kaiser L; Krishnan KR; Reuning-Scherer J; Gulanski B
    Neurology; 1997 Jun; 48(6):1511-7. PubMed ID: 9191757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the reliability of ADAS-Cog change scores.
    Grochowalski JH; Liu Y; Siedlecki KL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
    Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
    Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alzheimer's Disease Assessment Scale: findings from a low-education population.
    Liu HC; Teng EL; Chuang YY; Lin KN; Fuh JL; Wang PN
    Dement Geriatr Cogn Disord; 2002; 13(1):21-6. PubMed ID: 11731711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil.
    Levine SZ; Yoshida K; Goldberg Y; Samara M; Cipriani A; Efthimiou O; Iwatsubo T; Leucht S; Furukawa TA
    Evid Based Ment Health; 2021 May; 24(2):56-61. PubMed ID: 33023920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.